Can Sarepta’s ELEVIDYS redefine Duchenne therapy? Inside the 3-year EMBARK data
Sarepta’s gene therapy ELEVIDYS shows 3-year durability in Duchenne muscular dystrophy. Find out what it means for patients, payers, and global rollout.
Nocion Therapeutics reveals new pain data: Is a platform pivot underway?
Find out how Nocion’s nocions™ could change pain treatment by silencing activated neurons without opioids. New preclinical data inside.
Novaliq targets uveitis with EyeSol-based NOV05: Can topical tacrolimus go intraocular?
Novaliq’s NOV05 enters Phase 2 trials for anterior uveitis. Can it deliver steroid-free, topical relief for inner-eye inflammation? Find out what’s next.
How United Therapeutics is betting on scaffold-based liver support in high-mortality ALF
United Therapeutics’ miroliverELAP showed positive phase 1 safety results in acute liver failure. Find out what this could mean for future liver support strategies.
Merz Therapeutics files XEOMIN pediatric spasticity indication with EMA following Phase 3 success
Merz Therapeutics files EMA application to expand XEOMIN for pediatric spasticity. Find out how this could shift the treatment landscape for cerebral palsy.
Why Aviva Bio’s deuterated testosterone may change hormone therapy for women
Aviva Bio’s AVA‑291 receives FDA development feedback for women’s testosterone therapy. See what makes it safer and what happens next in clinical trials.
Can smart dental devices redefine sleep disorder treatment? Aesyra’s trial says yes
Aesyra’s AesyBite Active reduced sleep bruxism by over 60% in trial. Find out what this could mean for digital therapeutics and FDA approval in 2026.
From Dript to Vitaline: A new phase for clinical hydration in the U.S. eldercare system
Vitaline rebrands from Dript IV Therapy to signal its shift toward clinical-grade hydration services in senior care. Find out what this change means now.
BD Research Cloud 7.0 introduces Horizon Panel Maker to automate complex experiment setup
BD launches an AI-powered panel design tool for flow cytometry. Find out how it’s reshaping immunology and cancer research automation.
Ozelle’s 100B-image diagnostic AI platform puts scale and precision at the center of care
Ozelle’s AI-powered CBM platform debuts at WHX Dubai 2026. Discover how modular, guided diagnostics are transforming primary and veterinary care workflows.